2096:HKG
Simcere Pharmaceutical Group Ltd
11,02 HK$
arrow_upward
+1,75%(+0,19) 1D
16 tet, 4:08:14 m.d., GMT+8 · HKD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 2096...
Hap
10,85 HK$
I lartë
11,29 HK$
I ulët
10,85 HK$
Kapitalizimi i tregut
28,30 mld
Vëllimi mesatar
4,02 mln
Vëllimi
5,80 mln
Dividendi
1,88%
Dividendi tremujor
0,05 HK$
Data e ndërprerjes së dividendit
18 qer 2025
Raporti çmim/fitim
16,54
Maksimumi 52-javor
14,38 HK$
Minimumi 52-javor
9,07 HK$
Fitimet për aksion
0,67 HK$
Aksionet në qarkullim
2,57 mld
Numri i punonjësve
7 mijë
Hap
10,85 HK$
I lartë
11,29 HK$
I ulët
10,85 HK$
Kapitalizimi i tregut
28,30 mld
Vëllimi mesatar
4,02 mln
Vëllimi
5,80 mln
Dividendi
1,88%
Dividendi tremujor
0,05 HK$
Data e ndërprerjes së dividendit
18 qer 2025
Raporti çmim/fitim
16,54
Maksimumi 52-javor
14,38 HK$
Minimumi 52-javor
9,07 HK$
Fitimet për aksion
0,67 HK$
Aksionet në qarkullim
2,57 mld
Numri i punonjësve
7 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Business Wire
·
14 minuta më parë
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR to Hold Listing Ceremony and First Investor Day at the Nasdaq Tower on Oct. 26; Three New Robotics Product Offerings Launched
Simply Wall Street
·
40 minuta më parë
KLA (KLAC) Stock Is Caught In A Historic Chip Equipment Losing Streak
Bloomberg.com
·
1 orë më parë
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Yahoo Finance
·
14 orë më parë
Michael Burry Warns of a Stock Market ‘Supervolcano’
Profili
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
Rreth Simcere Pharmaceutical Group Ltd
Drejtori ekzekutivRen Jinsheng
Punonjësit7,06 mijë
Themeluar më1995
SeliaNanjing, Jiangsu, Kinë
Sektori-
Uebsajtisimcere.com